huberman lab bpc 157 NEW podcast episode is up! Dr. Andrew — Peptides, Performance, and Protocols Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at BPC-157 Benefits, Dosage & Before/After

Lynch, G

(9) N.Jelovac et al (1999) Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats European Journal of Pharmacology, 1999 Aug 20;379(1):19-31

Nasal formulas from reputable peptide sources have recently become available for researchers to explore this promising means of application, as detailed below

Funding Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB)

Different stability and pH profiles can degrade the solution

BPC 157 is not a substance that is legal or in compliance with the FDA for use in humans (1)